Article Text

Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality
  1. N Barber
  1. Department of Practice and Policy, The School of Pharmacy, 29–39 Brunswick Square, London WC1N 1AX, UK;

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    E Mossialos, M Mrazek, T Walley, Eds. UK: Cornwall, 2004, £24.99, ISBN 0335214657

    Few markets are as controlled by government as pharmaceuticals. Medicines permeate health care, are a major source of health care, and are made by one of the world’s most successful high technology industrial groups—the pharmaceutical industry. In Europe there exists both socialised healthcare systems and one of the few high tech industries in which Europe can compete with the USA and Japan. The European Union as a whole, and particularly the countries which have a thriving pharmaceutical industry, want to maintain a strong and competitive industry which provides substantial tax income and very significant …

    View Full Text